Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00254761 · ClinicalTrials.gov registry record · Phase 1
Effects of Smoked Marijuana on Neuropathic Pain
A Phase 1 study of Neuropathic Pain, sponsored by Center for Medicinal Cannabis Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT00254761 is a Phase 1 study of Neuropathic Pain that has completed, run by Center for Medicinal Cannabis Research. The registered enrollment target is 28 participants, below the 100-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00254761, a Phase 1 study of Neuropathic Pain, has completed, sponsored by Center for Medicinal Cannabis Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if smoking marijuana will reduce neuropathic pain without causing too much drowsiness or feeling "too dopey".
Conditions Studied
Interventions
- DRUG Cannabis
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2003-11 |
| Est. Completion | 2006-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00254761
The ClinicalTrials.gov registry entry for NCT00254761 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (72% lower). The listed sponsor is Center for Medicinal Cannabis Research, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neuropathic Pain appearing as the primary indexed condition, and to 1 intervention - of which Cannabis is the first listed.
NCT00254761 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00254761 about?
NCT00254761 is a clinical study titled "Effects of Smoked Marijuana on Neuropathic Pain". To determine if smoking marijuana will reduce neuropathic pain without causing too much drowsiness or feeling "too dopey".
What is the current status of trial NCT00254761?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2003-11. Estimated completion is 2006-02.
What conditions does trial NCT00254761 study?
This clinical trial studies the following conditions: Neuropathic Pain.
What interventions are being tested in trial NCT00254761?
The interventions under investigation include: Cannabis (DRUG).
Who is sponsoring clinical trial NCT00254761?
This trial is sponsored by Center for Medicinal Cannabis Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00254761 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuropathic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of CBD/CBD-A Oral Extract on Resting-state EEG and Neuropathic Pain Symptoms After SCI
RECRUITING · Phase 1
-
Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury
RECRUITING · Phase 1
-
Topical Naloxone to Diagnose Ocular Pain
COMPLETED · Phase 1
-
Tariquidar-ondansetron Combination in Neuropathic Pain
COMPLETED · Phase 1
-
Virtual Reality (VR) Self-Hypnosis Software
RECRUITING · NA
-
Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.